Notice of General Meeting and sample Proxy Form (1)
Released
Released
Announcement PDF
Notice of General Meeting
Invion Limited ACN 094 730 417
Notice is given that a General Meeting of Invion Limited ACN 094 730 417 (Company) will be held:
Location
At the offices of McCullough Robertson Lawyers, Level 11, 66 Eagle Street,
Brisbane, QLD 4000
Date
On Monday 25 May 2015
Time
At 10.00am (Brisbane time)
Special Business
Ratification and approval of previous allotment and issue of Shares under the Share
Purchase and Convertible Security Agreement (SPCSA) with the Australian Special
Opportunity Fund, LP (ASOF)
To consider and, if in favour, to pass the following resolution as an ordinary resolution:
1
‘That for the purposes of ASX Listing Rule 7.4 and for all other purposes, shareholders ratify and
approve the previous issue of 30,021,420 Shares, issued under the SPCSA with ASOF, announced by
the Company on 10 November 2014, as detailed in the Explanatory Memorandum accompanying
this Notice.’
The Directors unanimously recommend that you vote in favour of this resolution.
Ratification and approval of previous allotment and issue of share options under the
SPCSA with ASOF
To consider and, if in favour, to pass the following resolution as an ordinary resolution:
2
‘That for the purposes of ASX Listing Rule 7.4 and for all other purposes, shareholders ratify and
approve the previous issue of 7,000,000 share options, issued under the SPCSA with ASOF,
announced by the Company on 10 November 2014, as detailed in the Explanatory Memorandum
accompanying this Notice.’
The Directors unanimously recommend that you vote in favour of this resolution.
Ratification and approval of previous allotment and issue of a convertible security
under the SPCSA with ASOF
To consider and, if in favour, to pass the following resolution as an ordinary resolution:
3
‘That for the purposes of ASX Listing Rule 7.4 and for all other purposes, shareholders ratify and
approve the previous issue of one (1) convertible security with a face value of $250,000, issued to
ASOF, as announced by the Company on 24 March 2015, as detailed in the Explanatory
Memorandum accompanying this Notice.’
The Directors unanimously recommend that you vote in favour of this resolution.
Invion Limited, 2015 Notice of General Meeting
1
Ratification and approval of previous allotment and issue of placement shares
To consider and, if in favour, to pass the following resolution as an ordinary resolution:
4
‘That for the purposes of ASX Listing Rule 7.4 and for all other purposes, shareholders ratify and
approve the previous issue of 35,826,290 Shares at an issue price of $0.025 (2.5 cents) per Share,
issued under a placement to institutional and sophisticated investors as detailed in the Explanatory
Memorandum accompanying this Notice.’
The Directors unanimously recommend that you vote in favour of this resolution.
Dated 15 April 2015
By order of the Board
Melanie Farris
Company Secretary
Invion Limited, 2015 Notice of General Meeting
2
Voting exclusion statement
Listing Rules
In accordance with Listing Rule 14.11, the Company will disregard votes cast by:
Resolution 1 - Ratification and approval
The Company will disregard any votes cast on this resolution by
of previous allotment and issue of Shares
ASOF or any of its associates.
under the SPCSA with ASOF
Resolution 2 - Ratification and approval
The Company will disregard any votes cast on this resolution by
of previous allotment and issue of share
ASOF or any of its associates.
options under the SPCSA with ASOF
Resolution 3 - Ratification and approval
The Company will disregard any votes cast on this resolution by
of previous allotment and issue of a
ASOF or any of its associates.
convertible security under the SPCSA
with ASOF
Resolution 4 - Ratification and approval
The Company will disregard any votes cast on this resolution by
of
any person who participated in the issue of Shares described in
previous
allotment
and
issue
placement shares
of
the Explanatory Memorandum or any of their associates.
However, the Company need not disregard a vote if:
(a)
it is cast by a person as proxy for a person who is entitled to vote, in accordance with the directions
on the proxy form; or
(b)
it is cast by the person chairing the meeting as proxy for a person who is entitled to vote, in
accordance with a direction on the proxy form to vote as the proxy decides.
Notes
(a)
Terms used in this Notice of Meeting which are defined in the Explanatory Memorandum have the
meaning given to them in the Explanatory Memorandum.
(b)
Subject to the Corporations Act, including sections 250R and 250BD, a Shareholder who is entitled
to attend and cast a vote at the meeting is entitled to appoint a proxy.
(c)
The proxy need not be a Shareholder of the Company. A Shareholder who is entitled to cast two
or more votes may appoint two proxies and may specify the proportion or number of votes each
proxy is appointed to exercise.
(d)
If you wish to appoint a proxy and are entitled to do so, then complete and return the attached
proxy form.
(e)
A corporation may elect to appoint a representative in accordance with the Corporations Act in
which case the Company will require written proof of the representative’s appointment which must
be lodged with or presented to the Company before the meeting.
(f)
The Company has determined under regulation 7.11.37 Corporations Regulations 2001 that for the
purpose of voting at the meeting or adjourned meeting, securities are taken to be held by those
persons recorded in the Company’s register of Shareholders as at 7.00pm (Sydney time) on
Saturday, 23 May 2015.
(g)
If you have any queries on how to cast your votes then call the Company Secretary on
+61 7 3295 0500 during business hours.
Invion Limited, 2015 Notice of General Meeting
3
Explanatory Memorandum
Invion Limited ACN 094 730 417 (Company)
This Explanatory Memorandum accompanies the Notice of Meeting for the General Meeting of the
Company to be held at the offices of McCullough Robertson Lawyers at Level 11, 66 Eagle Street, Brisbane,
Queensland 4000 on Monday 25 May 2015, at 10.00am (Brisbane time).
The Explanatory Memorandum has been prepared to assist Shareholders in determining how to vote on the
resolutions set out in the Notice of Meeting and is intended to be read in conjunction with the Notice of
Meeting.
Resolution 1 - Ratification and approval of previous allotment and issue of Shares under
the Share Purchase and Convertible Security Agreement (SPCSA) with the Australian
Special Opportunity Fund, LP (ASOF)
1
The purpose of Resolution 1 is for Shareholders to approve, pursuant to Listing Rule 7.4, Shares issued
pursuant to the SPCSA with ASOF, announced by the Company on 10 November 2014, which will
otherwise count toward the 15% limit under Listing Rule 7.1 and 10% limit under Listing Rule 7.1A.
2
Listing Rule 7.1 provides that, subject to certain exceptions, none of which are relevant here, prior
approval of Shareholders is required for an issue of securities if the securities will, when aggregated
with the securities issued by a company during the previous 12 months, exceed 15% of the number
of the Shares on issue at the commencement of that 12 month period.
3
The allotment and issue of Shares detailed in this resolution did not exceed the 15% threshold.
However, Listing Rule 7.4 provides that where a company subsequently approves an issue of
securities, the issue will be treated as having been made with approval for the purpose of Listing
Rules 7.1 and 7.1A, thereby replenishing that company’s 15% capacity and additional 10%
capacity, enabling it to issue further securities up to that limit.
4
Resolution 1 proposes the approval of the previous allotment and issue of Shares for the purpose of
satisfying the requirements of Listing Rule 7.4. In compliance with the information requirements of
Listing Rule 7.5, members are advised of the following particulars in relation to the various
allotments and issuances (which in aggregate comprises 30,021,420 Shares):
Invion Limited, 2015 General Meeting: Explanatory Memorandum
1
Information
Disclosure
Date of issue
10 November 2014
Number of Shares issued
1,663,8941
Issue price and terms of
Shares were issued as 1st Commitment Shares under the SPCSA. The deemed
issue
issue price was $0.061 (6.1 cents) per Share. The Shares were issued as fully
paid ordinary shares, ranking equally with all other ordinary shares and having
identical rights to existing ordinary shares and are quoted on ASX.
Persons to whom the
Shares were issued to ASOF, pursuant to the SPCSA announced by the
Shares were issued
Company on 10 November 2014.
The intended use of
Not applicable as issued in lieu of a commitment fee.
funds raised
Information
Disclosure
Date of issue
21 November 2014
Number of Shares issued
1,663,894
Issue price and terms of
Shares were issued as 2nd Commitment Shares under the SPCSA. The deemed
issue
issue price was $0.061 (6.1 cents) per Share. The Shares were issued as fully
paid ordinary shares, ranking equally with all other ordinary shares and having
identical rights to existing ordinary shares and are quoted on ASX.
Persons to whom the
Shares were issued to ASOF, pursuant to the SPCSA announced by the
Shares were issued
Company on 10 November 2014.
The intended use of
Not applicable as issued in lieu of a commitment fee.
funds raised
Information
Disclosure
Date of issue
21 November 2014
Number of Shares issued
3,000,000
Issue price and terms of
Shares were issued as Collateral Shares under the SPCSA. The deemed issue
issue
price was $0.061 (6.1 cents) per Share. The Shares were issued as fully paid
ordinary shares, ranking equally with all other ordinary shares and having
identical rights to existing ordinary shares and are quoted on ASX.
Persons to whom the
Shares were issued to ASOF, pursuant to the SPCSA announced by the
Shares were issued
Company on 10 November 2014.
The intended use of
Not applicable as issued in lieu of security under the SPCSA.
funds raised
1
The issue of the 1st Commitment Shares was made under Listing Rule 7.1A.
Invion Limited, 2015 General Meeting: Explanatory Memorandum
2
Information
Disclosure
Date of issue
18 December 2014
Number of Shares issued
6,521,739
Issue price and terms of
The issue price was $0.046 (4.6 cents) per Share. The Shares were issued as fully
issue
paid ordinary shares, ranking equally with all other ordinary shares and having
identical rights to existing ordinary shares and are quoted on ASX.
Persons to whom the
Shares were issued to ASOF, pursuant to the SPCSA announced by the
Shares were issued
Company on 10 November 2014.
The intended use of
Funds raised under the SPCSA have been used for the Company’s general
funds raised
working capital, and specifically applied to costs associated with the ongoing
development of INV102 (nadolol), INV103 (ala-Cpn10) and INV104 (zafirlukast),
including regulatory costs; the development and maintenance of Invion’s
intellectual property portfolio; three phase II clinical programs and a feasibility
program for inhaled INV102 and INV104.
Information
Disclosure
Date of issue
21 January 2015
Number of Shares issued
10,000,000
Issue price and terms of
The issue price was $0.040 (4.0 cents) per Share. The Shares were issued as fully
issue
paid ordinary shares, ranking equally with all other ordinary shares and having
identical rights to existing ordinary shares and are quoted on ASX.
Persons to whom the
Shares were issued to ASOF, pursuant to the SPCSA announced by the
Shares were issued
Company on 10 November 2014.
The intended use of
Funds raised under the SPCSA have been used for the Company’s general
funds raised
working capital, and specifically applied to costs associated with the ongoing
development of INV102 (nadolol), INV103 (ala-Cpn10) and INV104 (zafirlukast),
including regulatory costs; the development and maintenance of Invion’s
intellectual property portfolio; three phase II clinical programs and a feasibility
program for inhaled INV102 and INV104.
Information
Disclosure
Date of issue
11 February 2015
Number of Shares issued
1,219,512
Issue price and terms of
The deemed issue price was $0.041 (4.1 cents) per Share. The Shares were
issue
issued on conversion of the previous convertible security under the SPCSA
(which has now been repaid), as fully paid ordinary shares, ranking equally
with all other ordinary shares and having identical rights to existing ordinary
shares and are quoted on ASX.
Persons to whom the
Shares were issued to ASOF, pursuant to the SPCSA announced by the
Shares were issued
Company on 10 November 2014.
The intended use of
Funds raised under the SPCSA have been used for the Company’s general
Invion Limited, 2015 General Meeting: Explanatory Memorandum
3
funds raised
working capital, and specifically applied to costs associated with the ongoing
development of INV102 (nadolol), INV103 (ala-Cpn10) and INV104 (zafirlukast),
including regulatory costs; the development and maintenance of Invion’s
intellectual property portfolio; three phase II clinical programs and a feasibility
program for inhaled INV102 and INV104.
Information
Disclosure
Date of issue
17 February 2015
Number of Shares issued
5,952,381
Issue price and terms of
The deemed issue price was $0.042 (4.2 cents) per Share. The Shares were
issue
issued on conversion of the previous convertible security under the SPCSA
(which has now been repaid), as fully paid ordinary shares, ranking equally
with all other ordinary shares and having identical rights to existing ordinary
shares and are quoted on ASX.
Persons to whom the
Shares were issued to ASOF, pursuant to the SPCSA announced by the
Shares were issued
Company on 10 November 2014.
The intended use of
Funds raised under the SPCSA have been used for the Company’s general
funds raised
working capital, and specifically applied to costs associated with the ongoing
development of INV102 (nadolol), INV103 (ala-Cpn10) and INV104 (zafirlukast),
including regulatory costs; the development and maintenance of Invion’s
intellectual property portfolio; three phase II clinical programs and a feasibility
program for inhaled INV102 and INV104.
Directors’ Recommendation
5
The Directors unanimously recommend that you vote in favour of this resolution.
Resolution 2 - Ratification and approval of previous allotment and issue of share options
under the SPCSA with ASOF
6
The purpose of Resolution 2 is for Shareholders to approve, pursuant to Listing Rule 7.4, share
options issued pursuant to the SPCSA with ASOF, announced by the Company on 10 November
2014, which will otherwise count toward the 15% limit under Listing Rule 7.1.
7
Listing Rule 7.1 provides that, subject to certain exceptions, none of which are relevant here, prior
approval of Shareholders is required for an issue of securities if the securities will, when aggregated
with the securities issued by a company during the previous 12 months, exceed 15% of the number
of the Shares on issue at the commencement of that 12 month period.
8
The allotment and issue of share options detailed in this resolution did not exceed the 15%
threshold. However, Listing Rule 7.4 provides that where a company subsequently approves an
issue of securities, the issue will be treated as having been made with approval for the purpose of
Listing Rule 7.1, thereby replenishing that company’s 15% capacity and enabling it to issue further
securities up to that limit.
9
Resolution 2 proposes the approval of the previous allotment and issue of share options for the
purpose of satisfying the requirements of Listing Rule 7.4. In compliance with the information
Invion Limited, 2015 General Meeting: Explanatory Memorandum
4
requirements of Listing Rule 7.5, members are advised of the following particulars in relation to the
allotments and issuances (which in aggregate comprises 7,000,000 share options):
Information
Disclosure
Date of issue
10 November 2014
Number of options issued
3,500,000
Issue price and terms of
Share options were issued as 1st Commitment Share Options under the SPCSA.
issue
Share options have an exercise price of $0.0721 per option and an expiry date
of 11 November 2017.
Persons to whom the
Share options were issued to ASOF, pursuant to the SPCSA announced by the
options were issued
Company on 10 November 2014.
The intended use of
Not applicable as issued in lieu of a commitment fee.
funds raised
Information
Disclosure
Date of issue
21 November 2014
Number of options issued
3,500,000
Issue price and terms of
Share options were issued as 2nd Commitment Share Options under the SPCSA.
issue
Share options have an exercise price of $0.0721 per option and an expiry date
of 22 November 2017.
Persons to whom the
Share options were issued to ASOF, pursuant to the SPCSA announced by the
options were issued
Company on 10 November 2014.
The intended use of
Not applicable as issued in lieu of a commitment fee.
funds raised
Resolution 3 - Ratification and approval of previous allotment and issue of a convertible
security to ASOF
10
The purpose of Resolution 3 is for Shareholders to approve, pursuant to Listing Rule 7.4, the issue of
one (1) convertible security to ASOF with a face value of $250,000, as announced by the Company
on 24 March 2015, the issue and conversion of which will otherwise count toward the 15% limit
under Listing Rule 7.1.
11
Listing Rule 7.1 provides that, subject to certain exceptions, none of which are relevant here, prior
approval of Shareholders is required for an issue of securities if the securities will, when aggregated
with the securities issued by a company during the previous 12 months, exceed 15% of the number
of the Shares on issue at the commencement of that 12 month period.
12
Assuming conversion into fully paid ordinary shares at 2.5 cents per Share, being the offer price for
Shares in the Company’s placement and entitlement offer, announced on 20 March 2015, the
convertible security would be convertible to a maximum of 10,000,000 fully paid ordinary shares.
13
If issued as at the date of this Notice of Meeting, the allotment and issue of 10,000,000 fully paid
ordinary shares detailed in this resolution would not exceed the 15% threshold.
Invion Limited, 2015 General Meeting: Explanatory Memorandum
5
14
Resolution 3 proposes the approval of the issue of one (1) convertible security for the purpose of
satisfying the requirements of Listing Rule 7.4. In compliance with the information requirements of
Listing Rule 7.5, members are advised of the following particulars in relation to the allotment and
issue:
Information
Disclosure
Date of issue
24 March 2015
Number of securities
one (1)
issued
Issue price and terms of
The convertible security was issued as compensation for the Company
issue
concluding its arrangements with ASOF under the SPCSA.
The convertible security is unsecured and has a face value of $250,000. It is
convertible into Shares, in amounts of no less than $10,000, after an initial lockup period to 15 December 2015, subject to certain events allowing for earlier
conversion. The conversion price per Share shall be the lesser of 2.5 cents and
the price per Share equal to 90% of the average of the three lowest daily
VWAPs per Share during the 20 consecutive trading days immediately prior to
the relevant conversion of the security.
Persons to whom the
The convertible security was issued to ASOF, as part of the conclusion of the
securities were issued
arrangements under the SPCSA, as announced by the Company on 20 March
2015.
The intended use of
Not applicable.
funds raised
Resolution 4 - Ratification and approval of previous allotment and issue of placement
shares
15
The purpose of Resolution 4 is for Shareholders to approve, pursuant to Listing Rule 7.4, those
securities issued in a placement to institutional and sophisticated investors which completed on 27
March 2015, which will otherwise count toward the 15% limit under Listing Rule 7.1.
16
Listing Rule 7.1 provides that, subject to certain exceptions, none of which are relevant here, prior
approval of Shareholders is required for an issue of securities if the securities will, when aggregated
with the securities issued by a company during the previous 12 months, exceed 15% of the number
of the Shares on issue at the commencement of that 12 month period.
17
The allotment and issue of securities detailed in this resolution did not exceed the 15% threshold.
However, Listing Rule 7.4 provides that where a company subsequently approves an issue of
securities, the issue will be treated as having been made with approval for the purpose of Listing
Rule 7.1, thereby replenishing that company’s 15% capacity and enabling it to issue further
securities up to that limit.
18
Resolution 4 proposes the approval of the previous allotment and issue of securities for the purpose
of satisfying the requirements of Listing Rule 7.4. In compliance with the information requirements of
Listing Rule 7.5, members are advised of the following particulars in relation to the allotment and
issue:
Invion Limited, 2015 General Meeting: Explanatory Memorandum
6
Information
Disclosure
Date of issue
27 March 2015
Number of Shares issued
35,826,290
Issue price and terms of
The issue price was $0.025 (2.5 cents) per Share. The Shares were issued as fully
issue
paid ordinary shares, ranking equally with all other ordinary shares and having
identical rights to existing ordinary shares and are quoted on ASX.
Persons to whom the
Institutional and sophisticated investors including clients and contacts of
Shares were issued
Morgans Corporate Limited and Patersons Securities Limited.
The intended use of
Funds raised will be used for the Company’s general working capital, and
funds raised
specifically applied to costs associated with the ongoing development of
INV102 (nadolol), INV103 (ala-Cpn10) and INV104 (zafirlukast), including
regulatory costs; the development and maintenance of Invion’s intellectual
property portfolio; three phase II clinical programs and a feasibility program
for inhaled INV102 and INV104.
Directors’ Recommendation
19
The Directors unanimously recommend that you vote in favour of this resolution.
Invion Limited, 2015 General Meeting: Explanatory Memorandum
7
Glossary
Invion Limited ACN 094 730 417
ASOF
means The Australian Special Opportunity Fund, LP.
ASX
means ASX Limited ABN 98 008 624 691 or the securities market which it
operates, as the context requires.
Board
means the board of directors of the Company.
Company
means Invion Limited ACN 094 730 417.
Constitution
means the constitution of the Company.
Corporations Act
means the Corporations Act 2001 (Cth).
Directors
means the directors of the Company.
Explanatory Memorandum
means the explanatory memorandum attached to the Notice of
Meeting.
General Meeting
means the Company’s general meeting being held on 25 May 2015,
and the subject of this Notice of Meeting.
Listing Rules
means the listing rules of ASX.
Notice of Meeting
means
the
notice
of
meeting
and
includes
the
Explanatory
Memorandum.
SPCSA
means the share purchase and convertible security agreement dated
10 November 2014 between the Company and ASOF.
Shareholder
means a person who is the registered holder of Shares.
Shares
means the existing fully paid ordinary shares in the Company.
Invion Limited, 2015 General Meeting: Explanatory Memorandum
8
LODGE YOUR VOTE
BY MAIL
Invion Limited
C/- Link Market Services Limited
Locked Bag A14
Sydney South NSW 1235 Australia
Invion Limited
FAX
BY
+61 2 9287 0309
ACN 094 730 417
HAND
BY
Link Market Services Limited
1A Homebush Bay Drive, Rhodes NSW 2138
ENQUIRIES TO
ALL
Telephone: 1300 554 474
*X99999999999*
X99999999999
PROXY FORM
I/We being a member(s) of Invion Limited and entitled to attend and vote hereby appoint:
APPOINT A PROXY
STEP 1
the Chairman of the
Meeting (mark box)
OR if you are NOT appointing the Chairman of the Meeting
as your proxy, please write the name of the person or
body corporate you are appointing as your proxy
or failing the person or body corporate named, or if no person or body corporate is named, the Chairman of the Meeting, as my/our proxy to
act on my/our behalf (including to vote in accordance with the following directions or, if no directions have been given and to the extent
permitted by the law, as the proxy sees fit) at the Extraordinary General Meeting of the Company to be held at 10:00am on Monday, 25 May
2015 at McCullough Robertson Lawyers, Level 11, 66 Eagle Street, Brisbane QLD 4000 (the Meeting) and at any postponement or
adjournment of the Meeting.
The Chairman of the Meeting intends to vote undirected proxies in favour of each item of business.
VOTING DIRECTIONS
Proxies will only be valid and accepted by the Company if they are signed and received no later than 48 hours before the Meeting.
Please read the voting instructions overleaf before marking any boxes with an T
STEP 2
Resolutions
For Against Abstain*
1 Ratification and approval of previous allotment and issue of Shares under the Share Purchase and Convertible
Security Agreement (SPCSA) with the Australian Special Opportunity Fund, LP (ASOF)
2 Ratification and approval of previous allotment and issue of share options under the SPCSA with ASOF
3 Ratification and approval of previous allotment and issue of a convertible security under the SPCSA with ASOF
4 Ratification and approval of previous allotment and issue of placement shares
STEP 3
SIGNATURE OF SHAREHOLDERS – THIS MUST BE COMPLETED
Shareholder 1 (Individual)
Joint Shareholder 2 (Individual)
Joint Shareholder 3 (Individual)
Sole Director and Sole Company Secretary
Director/Company Secretary (Delete one)
Director
This form should be signed by the shareholder. If a joint holding, either shareholder may sign. If signed by the shareholder’s attorney, the
power of attorney must have been previously noted by the registry or a certified copy attached to this form. If executed by a company, the
form must be executed in accordance with the company’s constitution and the Corporations Act 2001 (Cth).
IVX PRX501F
*IVX PRX501*
If you mark the Abstain box for a particular Item, you are directing your proxy not to vote on your behalf on a show of hands or on a poll and your
* votes
will not be counted in computing the required majority on a poll.
HOW TO COMPLETE THIS SHAREHOLDER PROXY FORM
YOUR NAME AND ADDRESS
This is your name and address as it appears on the Company’s share
register. If this information is incorrect, please make the correction on
the form. Shareholders sponsored by a broker should advise their broker
of any changes. Please note: you cannot change ownership of your
shares using this form.
APPOINTMENT OF PROXY
If you wish to appoint the Chairman of the Meeting as your proxy, mark
the box in Step 1. If you wish to appoint someone other than the Chairman
of the Meeting as your proxy, please write the name of that individual or
body corporate in Step 1. A proxy need not be a shareholder of the
Company.
LODGEMENT OF A PROXY FORM
This Proxy Form (and any Power of Attorney under which it is signed)
must be received at an address given below by 10:00am on Saturday,
23 May 2015, being not later than 48 hours before the commencement
of the Meeting. Any Proxy Form received after that time will not be
valid for the scheduled Meeting.
Proxy Forms may be lodged using the reply paid envelope or:
BY MAIL
Invion Limited
C/- Link Market Services Limited
Locked Bag A14
Sydney South NSW 1235
Australia
DEFAULT TO CHAIRMAN OF THE MEETING
Any directed proxies that are not voted on a poll at the Meeting will default
to the Chairman of the Meeting, who is required to vote those proxies as
directed. Any undirected proxies that default to the Chairman of the
Meeting will be voted according to the instructions set out in this Proxy
Form.
VOTES ON ITEMS OF BUSINESS – PROXY APPOINTMENT
You may direct your proxy how to vote by placing a mark in one of the
boxes opposite each item of business. All your shares will be voted in
accordance with such a direction unless you indicate only a portion of
voting rights are to be voted on any item by inserting the percentage or
number of shares you wish to vote in the appropriate box or boxes. If you
do not mark any of the boxes on the items of business, your proxy may
vote as he or she chooses. If you mark more than one box on an item your
vote on that item will be invalid.
BY FAX
+61 2 9287 0309
BY HAND
delivering it to Link Market Services Limited*
1A Homebush Bay Drive
Rhodes NSW 2138
* During business hours (Monday to Friday, 9:00am–5:00pm)
APPOINTMENT OF A SECOND PROXY
You are entitled to appoint up to two persons as proxies to attend the
Meeting and vote on a poll. If you wish to appoint a second proxy, an
additional Proxy Form may be obtained by telephoning the Company’s
share registry or you may copy this form and return them both together.
To appoint a second proxy you must:
(a) on each of the first Proxy Form and the second Proxy Form state the
percentage of your voting rights or number of shares applicable to that
form. If the appointments do not specify the percentage or number of
votes that each proxy may exercise, each proxy may exercise half your
votes. Fractions of votes will be disregarded; and
(b) return both forms together.
SIGNING INSTRUCTIONS
You must sign this form as follows in the spaces provided:
Individual: where the holding is in one name, the holder must sign.
Joint Holding: where the holding is in more than one name, either
shareholder may sign.
Power of Attorney: to sign under Power of Attorney, you must lodge the
Power of Attorney with the registry. If you
Share your feedback
Discover